Inman v. Mead Johnson Reaches Jury Selection After Three Prior Daubert Failures
Three consecutive federal bellwether trials in the NEC infant-formula MDL ended at summary judgment in 2025 because plaintiff causation experts were excluded under Daubert. That streak appears to have ended. Jury selection in Inman v. Mead Johnson, MDL 3026, S.D. Ill. (Judge Rebecca Pallmeyer), is set for July 6, 2026, and this time a plaintiff epidemiologist will testify before a federal NEC jury for the first time in the litigation's history.
The central ruling is Judge Pallmeyer's denial of Mead Johnson's Daubert motion targeting plaintiff epidemiologist Dr. Logan Spector. Defense counsel argued that Dr. Spector's reliance on observational epidemiological studies and Bradford Hill criteria was methodologically insufficient for dose-response causation. The court disagreed, finding his methodology satisfied the reliability threshold under Federal Rule of Evidence 702. The ruling does not formally bind the 798 active MDL cases counted as of June 2026, but it establishes the template for expert retention across the inventory.
Plaintiff firms that lost prior federal bellwethers on Daubert grounds should treat the Spector ruling as a retooling signal for expert packages. The choice of epidemiologist, the structure of their causation analysis, and the specificity of dose-response methodology will all be subject to renewed scrutiny if Inman generates a defense verdict.
Plaintiff counsel with federal NEC cases pending in MDL 3026 should compare their retained expert methodologies against the Spector framework before the Inman verdict issues.
Missouri Affirms $495 Million Gill v. Abbott Verdict and Rejects the Learned-Intermediary Defense
The Missouri Court of Appeals' May 2026 affirmance of the $495 million verdict in Gill v. Abbott Laboratories is a doctrinal event, not just a financial one. The panel upheld $95 million in compensatory damages and $400 million in punitive damages. More consequential for plaintiff counsel nationwide is the court's ruling on the learned-intermediary defense: the court held that preterm cow-milk infant formula is food, not a prescription medical product, and declined to extend the doctrine to this context.
The learned-intermediary doctrine would have required plaintiff counsel to establish that Abbott's warning to the prescribing physician was inadequate, rather than that the warning to the consumer was deficient. By classifying infant formula as food, the court removed that shield. TorHoerman Law served as lead plaintiff counsel through trial and the appeal.
The ruling does not bind Illinois or Pennsylvania courts where parallel NEC litigation is active. It is, however, persuasive authority, and plaintiff firms are already citing the learned-intermediary analysis in motions practice in other jurisdictions. Defense counsel in those states will argue the Missouri classification does not travel; plaintiff counsel should anticipate that fight and brief it early.
Plaintiff firms in NEC cases outside Missouri should attach the Gill learned-intermediary analysis to any pending motions in limine targeting defendant warning-defense theories.
Cook County NEC Trial Yields $70 Million for Four Families
An April 2026 Cook County Circuit Court jury awarded four NEC plaintiff families a combined $70 million against Abbott Laboratories. This was the first multi-family Illinois NEC trial and the third major state-court plaintiff win in the NEC litigation cycle. Cumulative state-court NEC plaintiff verdicts now exceed $625 million across three cases.
The logistical complexity of presenting four separate families' damages to a single jury is significant. Plaintiff counsel succeeded in that structure, which means the trial approach is replicable for firms managing larger NEC state-court inventories. The result also adds weight to coordinated state proceedings, where consolidation can reduce per-case trial costs without sacrificing individualized damages presentation.
Medical providers treating NEC survivors should note that the combined verdict reflects individualized damages across four plaintiffs. Providers whose records document the full range of NEC sequelae, including short-gut syndrome, neurodevelopmental delay, and feeding-tube dependency, are well-positioned to support damages discovery in future state proceedings. Comprehensive, longitudinal clinical documentation directly affects life-care plan valuations at trial.
Illinois NEC plaintiff counsel should evaluate whether the Cook County multi-plaintiff trial model applies to pending coordinated state-court inventories before the next trial setting.
Four Q1 2026 Verdicts Signal Strength in Med-Mal Outside NEC
Four Q1 2026 verdicts extend the notable-result picture beyond formula litigation. In Mobile County Circuit Court, Alabama, a March 2026 jury returned a $50 million wrongful-death verdict after providers failed to diagnose a life-threatening coronary artery blockage and sent the patient home. The patient died after discharge. The core theory, failure to recognize and treat a time-sensitive cardiac event, is well-established in Alabama med-mal practice, and the $50 million result includes a punitive component reflecting what plaintiff counsel characterized as inadequate triage protocols.
Philadelphia County Court of Common Pleas entered a $108.6 million birth-injury verdict in March 2026 arising from a 2018 delivery. Plaintiff alleged permanent brain injury caused by improper forceps use during labor and delivery. Pennsylvania birth-injury verdicts at this scale are not routine; the result signals substantial exposure for OBGYN and maternal care defendants on older inventories still moving through the system.
Cook County's $56 million med-mal verdict, with post-judgment interest pushing the total above $66 million, arose from a physician's failure to provide postoperative monitoring. The patient died from untreated internal hemorrhage while unattended in a recovery room. That figure places this verdict among the largest med-mal verdicts in Illinois history, and the liability theory maps cleanly onto hospital-systems protocols cases.
A separate Philadelphia County result, the $35 million verdict for plaintiff Isis Spencer, arose from a false-positive cancer diagnosis traced to contaminated biopsy slides at Main Line Health. A subsequent Penn Medicine biopsy showed no malignancy. The full hysterectomy performed on the basis of the erroneous pathology result anchors the damages claim. Cross-lab pathology-error liability is an emerging area, and Spencer illustrates how chain-of-custody failures between testing facilities can create multi-defendant exposure.
Firms building med-mal inventories in Illinois, Alabama, and Pennsylvania should factor these Q1 2026 verdicts into mediation demand calculations for similar fact patterns before Q3 settlement conferences.
FMCSA CDL Integrity Rule Opens Negligent-Entrustment Discovery in Trucking Cases
Effective March 16, 2026, the FMCSA's final rule titled 'Restoring Integrity to the Issuance of Non-Domiciled Commercial Drivers Licenses' tightens CDL issuance standards for drivers not domiciled in the licensing state. Plaintiff trucking attorneys are flagging the rule as a new negligent-entrustment discovery avenue, and the practical application is straightforward.
When a defendant motor carrier cannot produce documentation showing its driver held a properly issued CDL that satisfies the new domicile-verification requirements, plaintiff counsel can use that gap to support a negligent-entrustment theory. Standard motor-carrier discovery packages should now include CDL issuance records documenting compliance with the March 2026 rule, in addition to prior employment verification and MVR packages that were already standard practice.
Medical providers and lien holders working with trucking plaintiff firms should understand that negligent-entrustment findings typically widen defendant exposure and increase case value. That directly affects lien resolution timing. If a carrier's CDL compliance failure surfaces as a liability multiplier during discovery, settlement negotiations will extend and providers should plan for longer resolution timelines before filing reduction requests or finalizing lien amounts.
Add CDL domicile-verification documentation to all trucking case discovery checklists immediately, the March 2026 FMCSA rule creates a negligent-entrustment hook that was not available in prior practice, and the defendants who cannot produce that paper trail are identifiable at the initial file review stage.